Skip to the page

Data / Form D filings / Werewool, Inc.

Werewool, Inc.: Form D filings

Werewool, Inc., a biotechnology company in Brooklyn, NY, filed 3 Form D notices with the SEC between 2022 and 2023. The latest, on April 6, 2023, reports $3.2 million sold of a $3.2 million offering to 2 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
710 PARKSIDE AVENUE, Brooklyn, NY, 11226
Phone
(914) 960-2713
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2020
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1947954

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 6, 2023New notice$3,249,999$3,249,9992Mar 31, 2023sec.gov
Mar 2, 2023New noticeIndefinite$01Feb 22, 2023sec.gov
Oct 13, 2022New notice$450,000$450,0002Oct 6, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Corinna ChenDirector
Valentina GomezExecutive Officer, Director
Theanne SchirosExecutive Officer
Chui-lian LeeExecutive Officer, Director
Michael KrelDirector

Other biotechnology companies in New York that filed recently

Every Form D from the week of Apr 3, 2023 · All recent filings in New York · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Werewool, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.